How Has the Wearable Injectors Market Evolved Historically and What is its Current Size?
The wearable injectors market has seen considerable growth due to a variety of factors.
• The size of the wearable injectors market has significantly expanded in the past few years. There's a forecasted increase from $8.84 billion in 2024 to a substantial $9.91 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%.
The historic growth has been fuelled by factors such as the management of chronic diseases, convenience for patients, technological progress, and the aging population.
What is the Forecasted Market Size and CAGR for the Wearable Injectors Market?
The wearable injectors market is expected to maintain its strong growth trajectory in upcoming years.
• In the ensuing years, the market size for wearable injectors is anticipated to expand swiftly, reaching $17.45 billion in 2029 with a compound annual growth rate (CAGR) of 15.2%.
This projected expansion in the forecast period can be ascribed to factors such as personalized medicine, remote patient tracking, drug enhancement, and chronic ailment management. The forecast period is also expected to be marked by key trends such as biologics and large molecules, dual-chamber wearables, connected and intelligent devices, and patch pump technology.
What Key Factors and Trends Are Driving The Growth Wearable Injectors Market?
Chronic conditions such as diabetes, cardiovascular diseases, and cancers growing prevalence has significantly influenced the amplification of the wearable injectors market. As an illustration, a report in April 2023 by the British Diabetic Association, a charity for those coping with diabetes in the UK, highlighted that there are around 4.3 million people presently diagnosed with diabetes in the country. Among these individuals, nearly 90% are identified with type 2 diabetes, nearly 8% with type 1 diabetes, and the remaining 2% have other forms of diabetes. This upsurge in the population of diabetic and chronic disease patients has led to an increased necessity for disease treatment, therefore propelling the wearable injectors market's expansion.
What Are The Market Segments In The Wearable Injectors Market?
The wearable injectors market covered in this report is segmented –
1) By Type: On-Body Injectors, Off-Body Injectors
2) By End-User: Hospitals, Clinics, Homecare setting
3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications
Subsegments:
1) By On-Body Injectors: Patch-Based Injectors, Adhesive-Based Injectors, Needle-Based Injectors, Needle-Free Injectors
2) By Off-Body Injectors: Belt-Based Injectors, Handheld Injectors, Clip-Based Injectors
Pre-Book The Wearable Injectors Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Wearable Injectors Market?
Several firms operating in the wearable injectors manufacturing sector are concentrating their efforts on innovating products such as on-body injectors (OBI), with the aim to boost patient comfort, enhance adherence to recommended treatments, and meet the increasing demand for self-administration of biologic medicines. An On-Body Injector (OBI) is a wearable medication deliverance tool designed to give medications subcutaneously over a certain time frame, providing convenience for patients who require either large-volume injections or dosages with specific timing. For example, Coherus BioSciences Inc., a biotechnology firm based in the US, introduced UDENYCA in February 2024. UDENYCA, an advanced medicine delivery tool, is built on the LTS Sorrel wearable platform and is specifically intended for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim. This drug is administered the day after a chemotherapy treatment to reduce the chances of febrile neutropenia, a condition marked by fever and low white blood cell count due to infections. The OBI delivers precise doses and offers convenience for patients by permitting at-home administration, thus eliminating the requirement for further clinic visits.
Who Are the Key Players In The Wearable Injectors Market?
Major companies operating in the wearable injectors market include:
• Amgen Inc.
• Becton Dickinson and Company (BD)
• Enable Injections LLC
• Insulet Corporation
• Ypsomed Holding AG
• Medtronic MiniMed Inc.
• Tandem Diabetes Care Inc.
• Valeritas Inc.
• West Pharmaceutical Services Inc.
• Sensile Medical AG
• Gerresheimer AG
• Dexcom Inc.
• Consort Medical plc
• United Therapeutics Corporation
• Bühler Motor GmbH
• Debiotech SA
• Cellnovo Group
• EoFlow Co. Ltd.
• CeQur SA
• Haselmeier AG
• Johnson & Johnson
• kaleo Inc.
• Mylan N.V.
• Nemera Development S.A.
• F. Hoffmann-La Roche Ltd
• Zosano Pharma Corporation
What Are The Regional Insights Into The Wearable Injectors Market?
North America was the largest region in the wearable injectors market in 2023. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
